A Review of: “An Introduction to Statistics in Early Phase Trials, by S. A. Julious, S. B. Tan, and D. Machin.”

By Patterson Scott  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 2, 2011-03 ,pp. : 362-363

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Review of: “Medical Statistics: A Textbook for the Health Sciences, Fourth Edition, by D. Machin, M. J. Campbell, and S. J. Walters”

By Dhar Sunil  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 5, 2008-09 ,pp. : 1036-1038

Taylor & Francis Ltd

Access to resources Recommend Favorite

Myelotoxicity and Dose Intensity of Chemotherapy: Reporting Practices From Randomized Clinical Trials

By Dale David C.   McCarter Gordon C.   Crawford Jeffrey   Lyman Gary H.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 3, 2003-07 ,pp. : 440-454

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Clinical Practice and Future Needs in Recombinant Human Granulocyte Colony-stimulating Factor Treatment: a Review of Randomized Trials in Clinical Haemato-oncology

By Johnsen HE  

The Journal of International Medical Research, Vol. 29, Iss. 2, 2001-03 ,pp. : 87-99

Field House Publishing

Access to resources Recommend Favorite

A Review of: “Bayesian Adaptive Methods for Clinical Trials, by S. M. Berry, B. P. Carlin, J. J. Lee, and P. Muller”

By Kerman Jouni  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 3, 2011-05 ,pp. : 578-580

Taylor & Francis Ltd

Access to resources Recommend Favorite